International audienceThese guidelines were developed by the psoriasis research group of the French Society of Dermatology with the aim of providing updated decision-making algorithms for the systemic treatment of adult patients with moderate-to-severe psoriasis. Our algorithms were generated after rigorous evaluation of existing guidelines on the treatment of psoriasis and of publications concerning new systemic treatments, not yet incorporated into existing guidelines. A total of nine existing guidelines and 53 publications related to new systemic treatments were found to meet our criteria for use in the generation of the algorithms. We have proposed two new algorithms to assess therapeutic responses, both of which incorporate emerging cr...
peer reviewedBackground: Impressive progress in new therapeutic options has been made for psoriasis....
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed fo...
International audienceThese guidelines were developed by the psoriasis research group of the French ...
Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Wes...
Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Wes...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Background and objectives: Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of ...
BACKGROUND: Impressive progress in new therapeutic options has been made for psoriasis. Treatments i...
peer reviewedBackground: Impressive progress in new therapeutic options has been made for psoriasis....
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed fo...
International audienceThese guidelines were developed by the psoriasis research group of the French ...
Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Wes...
Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Wes...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis is a common disease, which has a considerable impact on the healthcare system. Therefore, ...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
Background and objectives: Since its inception, the Psoriasis Group (GPs) of the Spanish Academy of ...
BACKGROUND: Impressive progress in new therapeutic options has been made for psoriasis. Treatments i...
peer reviewedBackground: Impressive progress in new therapeutic options has been made for psoriasis....
Psoriasis vulgaris is a common and often chronic inflammatory skin disease. The incidence of psorias...
This evidence‐ and consensus‐based guideline on the treatment of psoriasis vulgaris was developed fo...